Works matching IS 10834389 AND DT 2021 AND VI 26 AND IP 5

Results: 17

Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12840

By:

Hsu, Ping‐I;
Tsay, Feng‐Woei;
Kao, John Y.;
Peng, Nan‐Jing;
Chen, Yan‐Hua;
Tang, Sheng‐Yeh;
Kuo, Chao‐Hung;
Kao, Sung‐Shuo;
Wang, Huay‐Min;
Wu, I‐Ting;
Shie, Chang‐Bih;
Chuah, Seng‐Kee;
Wu, Deng‐Chyang

Publication type:

Article

Favorable outcomes of rescue second‐ or third‐line culture‐based Helicobacter pylori eradication treatment in areas of high antimicrobial resistance.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12844

By:

Lee, Jung Won;
Kim, Nayoung;
Nam, Ryoung Hee;
Jang, Jae Young;
Choi, Yonghoon;
Lee, Dong Ho

Publication type:

Article

Dietary multivalent anti‐Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12843

By:

Guo, Rong;
Wu, Shan;
Guan, Li;
Xie, Yongmei;
Yang, Xifei;
Li, Zaixin;
Zhang, Zhi

Publication type:

Article

Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12837

By:

Kowada, Akiko;
Asaka, Masahiro

Publication type:

Article

Application of molecular techniques in Helicobacter pylori detection: limitations and improvements.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12841

By:

Gong, Lan;
El‐Omar, Emad M

Publication type:

Article

Doxycycline and minocycline in Helicobacter pylori treatment: A systematic review and meta‐analysis.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12839

By:

Zhao, Jixiang;
Zou, Yunzhi;
Li, Ke;
Huang, Xin;
Niu, Changping;
Wang, Zikang;
Zhao, Shuyang;
Zhang, Yizhen;
Song, Conghua;
Xie, Yong

Publication type:

Article

Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta‐analysis.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12838

By:

Ouyang, Yaobin;
Zhang, Wenjing;
Huang, Yancheng;
Wang, Yao;
Shao, Qing;
Wu, Xidong;
Lu, Nonghua;
Xie, Chuan

Publication type:

Article

Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12842

By:

Li, Nianshuang;
Xu, Xinbo;
Yang, Hui;
Wang, Huan;
Ouyang, Yaobin;
Zhou, Yanan;
Peng, Chao;
Yuan, Zhenxiang;
He, Cong;
Zeng, Chunyan;
Hong, Junbo

Publication type:

Article

Association between bacteria other than Helicobacter pylori and the risk of gastric cancer.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12836

By:

Gunathilake, Madhawa;
Lee, Jeonghee;
Choi, Il Ju;
Kim, Young‐Il;
Kim, Jeongseon

Publication type:

Article

Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12835

By:

Ouyang, Yaobin;
Zhu, Zhihao;
Huang, Li;
Zeng, Chuanfei;
Zhang, Lin;
Wu, William KK;
Lu, Nonghua;
Xie, Chuan

Publication type:

Article

cagA+ Helicobacter pylori infection and N‐nitrosodimethylamine and cholangiocarcinoma.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12834

By:

Mungmunpuntipantip, Rujittika;
Wiwanitkit, Viroj

Publication type:

Article

10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12833

By:

Zou, Pei‐Ying;
Hu, Jie;
Zhao, Jing‐Tao;
Zhao, Zhe;
Mei, Hao;
Yang, Jing;
Zhu, Yang‐Jie;
Zhang, Yi;
Lan, Chun‐Hui

Publication type:

Article

Reply to letter to the editor.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12831

By:

Dangtakot, Rungtiwa;
Intuyod, Kitti;
Chamgramol, Yaovalux;
Pairojkul, Chawalit;
Pinlaor, Somchai;
Jantawong, Chanakan;
Pongking, Thatsanapong;
Haonon, Ornuma;
Ma, Ning;
Pinlaor, Porntip

Publication type:

Article

Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12830

By:

Gunaratne, Anoja W;
Hamblin, Harrison;
Clancy, Annabel;
Magat, Aleja Jane Marie C;
Dawson, Marie Vic M;
Tu, Jeffrey;
Borody, Thomas J

Publication type:

Article

Issue Information.

Published in:: Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12711
Publication type:: Article

Application of WeChat platform in the management of patients infected with Helicobacter pylori.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12832

By:

Ma, Huan;
Zhao, Xin‐hua;
Zhang, Li‐li;
Wu, Li‐meng

Publication type:

Article

IL‐9 contributes to the host immune response against Helicobacterpylori and helps limit infection in a Mouse Model.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12827

By:

He, Yafei;
Ning, Jie;
Li, Bin;
Guo, Hong;
Hao, Ningbo;
Wu, Chao

Publication type:

Article